Reimbursement of anti-obesity drugs: a minimum cost for Health Insurance?
⚡ Quick Summary
The coverage of Wegovy and Mounjaro, used in the treatment of obesity from this Monday, June 15, could ultimately prove less expensive than expected for public accounts. A winning strategy for the State and the labs.
📰 Related Articles
Retail: the silent war to conquer the Moroccan shopping basket
Médias24
Global warming: the threshold of +1.5°C soon to be reached
France 24
Heatwave nights: Why your brain overheats and Dr. Gérald Kierzek's advice for sleeping better
Doctissimo
Consumer Recall Alert: Check your cupboards, these pan-fried gnocchi are subject to an immediate allergen recall
Doctissimo
Eviction in Ivory Coast: Modernity must not kill the citizen
Connectionivoirienne